Aubry A F, Markoglou N, McGann A
Department of Oncology, McGill University, Montreal, Que, Canada.
Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1995 Nov;112(3):257-66. doi: 10.1016/0742-8413(95)02019-5.
The binding of warfarin, a series of non-steroidal anti-inflammatory drugs and a series of benzodiazepines to rat serum albumin (RatSA) and rabbit serum albumin (RabSA) was compared with their binding to human serum albumin (HSA) using high-performance liquid chromatography on stationary phases based on immobilized albumins. The effect of the addition to the mobile phase of compounds known to bind to HSA at site I (phenylbutazone) or at site II (R- and S-ibuprofen) or at both sites (2,3,5-triiodobenzoic acid) was investigated on all three proteins. The results indicated that for the chiral compounds studied, the stereoselectivity of drug binding was much lower on RatSA than on HSA. On RatSA and RabSA, the benzodiazepine site was not a major binding site for R- and S-ibuprofen. The results indicated the existence of two binding sites for R and S warfarin on RatSA and probably on RabSA. On RatSA, one site is the major stereoselective site and is the major binding site of phenylbutazone and piroxicam. The other one is a major binding site for R- and S-ibuprofen and R- and S-ketoprofen.
采用基于固定化白蛋白的高效液相色谱法,比较了华法林、一系列非甾体抗炎药和一系列苯二氮䓬类药物与大鼠血清白蛋白(RatSA)、兔血清白蛋白(RabSA)的结合情况及其与人血清白蛋白(HSA)的结合情况。研究了在流动相中添加已知在I位点(保泰松)、II位点(R-和S-布洛芬)或两个位点(2,3,5-三碘苯甲酸)与HSA结合的化合物对这三种蛋白质的影响。结果表明,对于所研究的手性化合物,药物在RatSA上的结合立体选择性远低于在HSA上的。在RatSA和RabSA上,苯二氮䓬类药物位点不是R-和S-布洛芬的主要结合位点。结果表明,R-和S-华法林在RatSA上可能也在RabSA上存在两个结合位点。在RatSA上,一个位点是主要的立体选择性位点,也是保泰松和吡罗昔康的主要结合位点。另一个是R-和S-布洛芬以及R-和S-酮洛芬的主要结合位点。